Silver Lining: Reduced Relapse with Chronic GVHD after Transplant for MDS.

Published in: Clinical cancer research : an official journal of the American Association for Cancer Research (2020)

Chronic GVHD following hematopoietic cell transplantation is associated with reduced relapse incidence in patients with leukemias. This impact has been investigated in myelodysplastic syndrome, showing a beneficial impact of limited chronic GVHD on transplant outcomes in a cohort of more than 3,000 patients.See related article by Konuma et al., p. 6483.

Keyphrases

allogeneic hematopoietic stem cell transplantation
ejection fraction
newly diagnosed
gold nanoparticles
prognostic factors
type diabetes
acute lymphoblastic leukemia
high resolution
metabolic syndrome
insulin resistance